Research Article

You have full text access to this OnlineOpen article

Retreatment with bortezomib alone or in combination for patients with multiple myeloma following an initial response to bortezomib†

  1. Raman Sood1,*,
  2. Harry Carloss2,
  3. Robert Kerr3,
  4. Jose Lopez4,
  5. Martin Lee5,
  6. Mark Druck6,
  7. Ian B. Walters7,
  8. Stephen J. Noga8

Article first published online: 30 JUL 2009

DOI: 10.1002/ajh.21517

Issue

American Journal of Hematology

American Journal of Hematology

Volume 84, Issue 10, pages 657–660, October 2009

Additional Information

How to Cite

Sood, R., Carloss, H., Kerr, R., Lopez, J., Lee, M., Druck, M., Walters, I. B. and Noga, S. J. (2009), Retreatment with bortezomib alone or in combination for patients with multiple myeloma following an initial response to bortezomib. Am. J. Hematol., 84: 657–660. doi: 10.1002/ajh.21517

Author Information

  1. 1

    Raman Sood Physician PC, Dunkirk, New York

  2. 2

    Western Kentucky Hematology/Oncology Group, Paducah, Kentucky

  3. 3

    Southwest Regional Cancer Center, Austin, Texas

  4. 4

    Cancer Care Centers of South Texas, Fredericksburg, Texas

  5. 5

    Park Nicollet Cancer Center, St Louis Park, Minnesota

  6. 6

    Combined Hematology Oncology Practice of New Jersey, Jersey City, New Jersey

  7. 7

    Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts

  8. 8

    Alvin & Lois Lapidus Cancer Institute, Sinai Hospital, Baltimore, Maryland

*Raman Sood Physician PC, Dunkirk, NY

  1. †

    Conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 25 SEP 2009
  2. Article first published online: 30 JUL 2009
  3. Accepted manuscript online: 30 JUL 2009 12:00AM EST
  4. Manuscript Accepted: 28 JUL 2009
  5. Manuscript Revised: 27 JUL 2009
  6. Manuscript Received: 3 APR 2009

Funded by

  • Millennium Pharmaceuticals, Inc.
  • Johnson & Johnson Pharmaceuticals Research & Development, LLC

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (109K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jordi Bruna, Albert Alé, Roser Velasco, Jessica Jaramillo, Xavier Navarro, Esther Udina, Evaluation of pre-existing neuropathy and bortezomib retreatment as risk factors to develop severe neuropathy in a mouse model, Journal of the Peripheral Nervous System, 2011, 16, 3
    Direct Link:
  2. 2
    N. Shah, S. Lonial, Evidence-Based Mini-Review: Treatment Options for Patients with Relapsed/Refractory Myeloma Previously Treated with Novel Agents and High-Dose Chemotherapy and Autologous Stem-Cell Transplantation, Hematology, 2011, 2010, 1, 310

    CrossRef

  3. 3
    Francesco Spina, Vittorio Montefusco, Claudia Crippa, Annalisa Citro, Simona Sammassimo, Barbara Olivero, Silvia Gentili, Monica Galli, Tommasina Guglielmelli, Davide Rossi, Antonietta Pia falcone, Mariella Grasso, Francesca Patriarca, Marianna De muro, Paolo Corradini, Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant, Leukemia & Lymphoma, 2011, 52, 7, 1262

    CrossRef

  4. 4
    S Sinha, M Lacy, J Mikhael, S Hayman, F Buadi, K Detweiler-Short, A Dispenzieri, M Gertz, D Dingli, S V Rajkumar, S K Kumar, Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy, Leukemia, 2011,

    CrossRef

  5. 5
    S K Kumar, J H Lee, J J Lahuerta, G Morgan, P G Richardson, J Crowley, J Haessler, J Feather, A Hoering, P Moreau, X LeLeu, C Hulin, S K Klein, P Sonneveld, D Siegel, J Bladé, H Goldschmidt, S Jagannath, J S Miguel, R Orlowski, A Palumbo, O Sezer, S V Rajkumar, B G M Durie, Niels Abildgaard, Rafat Abonour, Ray Alexanian, Melissa Alsina, Kenneth, C Anderson, Michael Attal, Hervé Avet-Loiseau, Ashraf Badros, Dalsu Baris, Bart Barlogie, Régis Bataille, Meral Beksaç, Andrew Belch, Dina Ben-Yehuda, Bill Bensinger, P Leif Bergsagel, Jenny Bird, Joan Bladé, Mario Boccadoro, Michele Cavo, Asher Chanan-Khan, Wen Ming Chen, Tony Child, James Chim, Wee-Joo Chng, Ray Comenzo, John Crowley, William Dalton, Faith Davies, Cármino de Souza, Michel Delforge, Meletios Dimopoulos, Angela Dispenzieri, Johannes Drach, Matthew Drake, Brian G M Durie, Hermann Einsele, Theirry Facon, Dorotea Fantl, Jean-Paul Fermand, Rafael Fonseca, Gösta Gahrton, Ramón García-Sanz, Christina Gasparetto, Morie Gertz, John Gibson, Sergio Giralt, Hartmut Goldschmidt, Philip Greipp, Roman Hajek, Izhar Hardan, Parameswaran Hari, Jean-Luc Harousseau, Hiroyuki Hata, Yutaka Hattori, Tom Heffner, Joy Ho, Vania Hungria, Shinsuke Ida, Peter Jacobs, Sundar Jagannath, Hans Johnsen, Hou Jian, Douglas Joshua, Artur Jurczyszyn, Michio Kawano, Nicolaus Kröger, Shaji Kumar, Robert A Kyle, Martha Lacy, Juan José Lahuerta, Ola Landgren, Jacob Laubach, Jae Hoon Lee, Xavier LeLeu, Suzanne Lentzsch, Henk Lokhorst, Sagar Lonial, Heinz Ludwig, Angelo Maiolino, María Mateos, Jayesh Mehta, Ulf-Henrik Mellqvist, GiamPaolo Merlini, Joseph Mikhael, Angelina Rodríguez Morales, Philippe Moreau, Gareth Morgan, Hareth Nari, Nikhil Munshi, Ruben Niesvizky, Amara Nouel, Yana Novis, Robert Orlowski, Antonio Palumbo, Santiago Pavlovsky, Linda Pilarski, Raymond Powles, Noopur Raje, S Vincent Rajkumar, Donna Reece, Tony Reiman, Paul G Richardson, David Roodman, Laura Rosiñol, Jesús San Miguel, Orhan Sezer, Jatin J Shah, John Shaughnessy, Kazuyuki Shimizu, Chaim Shustik, David Siegel, Seema Singhal, Pieter Sonneveld, Andrew Spencer, Edward Stadtmauer, Keith Stewart, Evangelos Terpos, Patrizia Tosi, Guido Tricot, Ingemar Turesson, Ben Van Camp, Brian Van Ness, Ivan Van Riet, Isabelle Vande Broek, Karin Vanderkerken, Robert Vescio, David Vesole, Anders Waage, Michael Wang, Donna Weber, Jan Westin, Keith Wheatley, Jeffrey Zonder, Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study, Leukemia, 2011, 26, 1, 149

    CrossRef

  6. 6
    Michael Fiegl, Florian Falkner, Michael Steurer, Niklas Zojer, Georg Hopfinger, Ferdinand Haslbauer, Guntram Winder, Daniela Voskova, Johannes Andel, Alois Lang, Yvona Brychtova, Jiri Mayer, Richard Greil, Günther Gastl, Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients, Annals of Hematology, 2011, 90, 9, 1083

    CrossRef

  7. 7
    Niels W.C.J. van de Donk, Henk M. Lokhorst, Meletios Dimopoulos, Michele Cavo, Gareth Morgan, Hermann Einsele, Martin Kropff, Steve Schey, Hervé Avet-Loiseau, Heinz Ludwig, Hartmut Goldschmidt, Pieter Sonneveld, Hans E. Johnsen, Joan Bladé, Jesús F. San-Miguel, Antonio Palumbo, Treatment of relapsed and refractory multiple myeloma in the era of novel agents, Cancer Treatment Reviews, 2011, 37, 4, 266

    CrossRef

  8. 8
    B Mohty, J El-Cheikh, I Yakoub-Agha, H Avet-Loiseau, P Moreau, M Mohty, Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and ‘retreatment’ approaches in the era of novel agents, Leukemia, 2011, 26, 1, 73

    CrossRef

  9. 9
    Gabriel N. Waterman, Ori Yellin, Regina A. Swift, Russell Mapes, Benjamin Eades, Emily Ackerman, James R. Berenson, A modified regimen of pegylated liposomal doxorubicin, bortezomib, and dexamethasone is effective and well tolerated in the treatment of relapsed or refractory multiple myeloma, Annals of Hematology, 2010, 90, 2, 193

    CrossRef

  10. 10
    Paul E Monahan, Clinton D Lothrop, Junjiang Sun, Matthew L Hirsch, Tal Kafri, Boris Kantor, Rita Sarkar, D Michael Tillson, Joseph R Elia, R Jude Samulski, Proteasome Inhibitors Enhance Gene Delivery by AAV Virus Vectors Expressing Large Genomes in Hemophilia Mouse and Dog Models: A Strategy for Broad Clinical Application, Molecular Therapy, 2010, 18, 11, 1907

    CrossRef

  11. 11
    Sundar Jagannath, Robert A. Kyle, Antonio Palumbo, David S. Siegel, Sonia Cunningham, James Berenson, The Current Status and Future of Multiple Myeloma in the Clinic, Clinical Lymphoma, Myeloma & Leukemia, 2010, 10, 1, E1

    CrossRef

  12. 12
    Sundar Jagannath, Robert A. Kyle, Antonio Palumbo, David S. Siegel, Sonia Cunningham, James Berenson, The Current Status and Future of Multiple Myeloma in the Clinic, Clinical Lymphoma, Myeloma & Leukemia, 2010, 10, 1, 28

    CrossRef

Get PDF (109K)